Product Images Tramadol Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Tramadol Hydrochloride NDC 59651-441 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure1 - tramadol fig1

figure1 - tramadol fig1

Clinical Studies Section - tramadol fig2

Clinical Studies Section - tramadol fig2

This seems to be a graph or chart showing the percentage of participants who discontinued a protocol (CAPSS-047) due to nausea/vomiting at specific times during the study. The X-axis shows the days in a double-blind period, and there appears to be a line showing time to discontinuation due to nausea/vomiting at a dosage of 200 mg/day. However, without context, it is difficult to provide a more specific description or interpretation of the data.*

tramadol-fig3 - tramadol fig3

tramadol-fig3 - tramadol fig3

This is a description of a medication named Tramadol Hydrochloride USP. The package is made in India and distributed by Aurobindo Pharma USA, Inc. The tablet's usual dosage and prescribing information is included in the accompanying package insert with a code of AP/DRUGS/04/2016. The tablets should be stored at a temperature range of 20° to 25°C (68° to 77°F) in a tight container. The medication guide is provided separately to each patient by the pharmacist. The packaging includes the NDC and other information including manufacturing details and precautions, like "keep out of the reach of children."*

structure - tramadol str

structure - tramadol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.